Covid Booster Dose
-
{
- All
- News
- Videos
-
UK Doctor Admits Trying To Kill Mother's Partner With Flesh-Eating Bacteria Under Guise Of Covid Shot
A doctor in the United Kingdom has admitted trying to kill his mother's long-term partner by injecting him with a fake Covid-19 booster that caused a flesh-eating bacterial disease.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
Covid-19: Here's Why You Should Get Covid Booster Shot If You Haven't Already
Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.
-
Only 12% People In 18-59 Age Group Have Taken Covid Booster Dose: Report
Around 12 per cent of the eligible 77 crore population in the age group of 18-59 years have taken the precaution dose of COVID-19 vaccine so far, officials said on Tuesday.
-
Free Covid Booster Dose For Adults At Government Centres For Next 75 Days
People aged 18 and above will get free precaution doses of the Covid vaccine at government vaccination centres from today under a 75-day special drive initiated by the Union Health Ministry.
-
Vaccine Panel Endorses Booster Before 9 Months If Flying Abroad: Report
The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.
-
Mix-And-Match Of Booster Shot Offers Best Protection Against Covid: Study
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal.
-
Covishield Booster At Rs 600 Plus Tax: Adar Poonawalla To NDTV
Mr Poonawala told NDTV that Covishield will cost Rs 600 plus taxes (same as before) and Covovax, once approved as a booster, will be available for Rs.900 plus taxes.
-
India Now Considering Boosters For All Adults: Report
Last week, the health ministry urged Indian states to boost surveillance measures for the disease, citing a resurgence in some parts of Asia and Europe. Countries such as China and Italy have seen a recent rise in cases.
-
"Vaccine 1st Dose Was Essentially A Booster": Top Medical Expert To NDTV
In India the first dose of the Covid vaccine - rolled out from January 16 last year amid concerns over delays in vaccination - was "essentially a booster", Dr Jayaprakash Muliyil of the Indian Council for Medical Research (ICMR), told NDTV.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Are Booster Doses Needed? Looking Into It, Centre Tells High Court
The Centre has told the Delhi High Court that the National Technical Advisory Group of Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence related to the
-
UK Doctor Admits Trying To Kill Mother's Partner With Flesh-Eating Bacteria Under Guise Of Covid Shot
A doctor in the United Kingdom has admitted trying to kill his mother's long-term partner by injecting him with a fake Covid-19 booster that caused a flesh-eating bacterial disease.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
Covid-19: Here's Why You Should Get Covid Booster Shot If You Haven't Already
Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.
-
Only 12% People In 18-59 Age Group Have Taken Covid Booster Dose: Report
Around 12 per cent of the eligible 77 crore population in the age group of 18-59 years have taken the precaution dose of COVID-19 vaccine so far, officials said on Tuesday.
-
Free Covid Booster Dose For Adults At Government Centres For Next 75 Days
People aged 18 and above will get free precaution doses of the Covid vaccine at government vaccination centres from today under a 75-day special drive initiated by the Union Health Ministry.
-
Vaccine Panel Endorses Booster Before 9 Months If Flying Abroad: Report
The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.
-
Mix-And-Match Of Booster Shot Offers Best Protection Against Covid: Study
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal.
-
Covishield Booster At Rs 600 Plus Tax: Adar Poonawalla To NDTV
Mr Poonawala told NDTV that Covishield will cost Rs 600 plus taxes (same as before) and Covovax, once approved as a booster, will be available for Rs.900 plus taxes.
-
India Now Considering Boosters For All Adults: Report
Last week, the health ministry urged Indian states to boost surveillance measures for the disease, citing a resurgence in some parts of Asia and Europe. Countries such as China and Italy have seen a recent rise in cases.
-
"Vaccine 1st Dose Was Essentially A Booster": Top Medical Expert To NDTV
In India the first dose of the Covid vaccine - rolled out from January 16 last year amid concerns over delays in vaccination - was "essentially a booster", Dr Jayaprakash Muliyil of the Indian Council for Medical Research (ICMR), told NDTV.
-
Booster Can Boost Effectiveness Against Omicron To 88%, UK Studies Show
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
-
Are Booster Doses Needed? Looking Into It, Centre Tells High Court
The Centre has told the Delhi High Court that the National Technical Advisory Group of Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence related to the
